Aetna
Aetna Aetna
Specialty Pharmacy Clinical Policy Bulletins
Aetna Non-Medicare Prescription Drug Plan
Subject: Specialty Quantity Limit Mekinist 1682-H P2023a

Drug
MEKINIST  (trametinib)


Policy:

      I.  PROGRAM DESCRIPTION

          The standard limit is designed to allow a quantity sufficient for
          the most common uses of the medication. The recommended
          dosing parameters for the treatment of all FDA-approved
          indications fall within the standard limits. Coverage of an
          additional quantity may be reviewed on a case-by-case basis
          upon request.


   II.  COVERED QUANTITIES
 

  Medication

  Standard Limit

  FDA-recommended dosing

  Mekinist (trametinib)
  0.5 mg tablet

  90 tablets
  per 30 days

  Adults: 2 mg once daily

  First dose reduction: 1.5 mg once
  daily
  Second dose reduction: 1 mg once
  daily

 

  Pediatric patients:

  26-37 kg: 1 mg once daily
  38-50 kg: 1.5 mg once daily
  51 kg or greater: 2 mg once daily

  Mekinist (trametinib)
  2 mg tablet

  30 tablets
  per 30 days

  Mekinist (trametinib)
  4.7 mg (0.05 mg/mL
  reconstituted)
  for oral solution

  12 bottles
  per 28 days

  Once daily based on body weight:

  8 kg

  6 mL (0.3 mg)

  9 kg

  7 mL (0.35 mg)

  10 kg

  7 mL (0.35 mg)

  11 kg

  8 mL (0.4 mg)

  12-13 kg

  9 mL (0.45 mg)

  14-17 kg

  11 mL (0.55 mg)

  18-21 kg

  14 mL (0.7 mg)

  22-25 kg

  17 mL (0.85 mg)

  26-29 kg

  18 mL (0.9 mg)

  30-33 kg

  20 mL (1 mg)

  34-37 kg

  23 mL (1.15 mg)

  38-41 kg

  25 mL (1.25 mg)

  42-45 kg

  28 mL (1.4 mg)

  46-50 kg

  32 mL (1.6 mg)

  ≥ 51 kg

  40 mL (2 mg)

   


Place of Service:

Outpatient

The above policy is based on the following references:
  1. Mekinist [package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corporation; May 2023.
Copyright Aetna Inc. All rights reserved. Pharmacy Clinical Policy Bulletins are developed by Aetna to assist in administering plan benefits and constitute neither offers of coverage nor medical advice. This Clinical Policy Bulletin contains only a partial, general description of plan or program benefits and does not constitute a contract. Aetna does not provide health care services and, therefore, cannot guarantee any results or outcomes. Participating providers are independent contractors in private practice and are neither employees nor agents of Aetna or its affiliates. Treating providers are solely responsible for medical advice and treatment of members. This Clinical Policy Bulletin may be updated and therefore is subject to change.

July 15, 2023
Aetna
Skip Past Footer Links
Company Information   |   Site Map Aetna.com Home   |   Help   |   Contact Us   |   Search
Web Privacy Statement   |   Legal Statement   |   Privacy Notices   |   Member Disclosure

Back to top